Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96
Published September 27, 2023 · Recall initiated: September 7, 2023
Summary
FDA records drug Class III recall D-1172-2023, published September 27, 2023 and initiated September 7, 2023. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Terminated; Reported quantity: 69,707 cartons; Lot: Lot# 10026, Lot 10027, Exp. 09/2023. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent: Out of Specification result observed for low assay
What to do
Voluntary: Firm initiated · Letter
Get an email if CEQUA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CEQUA
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Distributor
- Nationwide wide in the USA
- Lot
- Lot# 10026, Lot 10027, Exp. 09/2023.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDARasagiline Tablets 0.5mg, 30-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.,September 27, 2023
- FDAKroger Mint Burst ANTISEPTIC MOUTH RINSE ANTIGINGIVITIS/ANTIPLAQUE (Eucalyptol 0.092%, menthol 0.042%, MethylSeptember 27, 2023
- FDABD ChloraPrep Clear, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) SterileSeptember 27, 2023
- FDASANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by:September 27, 2023
- FDACequa (cyclosporine ophthalmic solution) 0.09%, packaged in 6 pouches x 10 single-use vials (0.25 mL each) perApril 13, 2022
- FDACequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mLMay 26, 2021
Questions about this recall
Was Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96 recalled?
Yes. FDA published recall D-1172-2023 on September 27, 2023. Reported hazard: Subpotent: Out of Specification result observed for low assay
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CEQUA.